March 3, 2026Open Access

KLF4 orchestrates a Ccl2+ fibroblast-mediated inflammatory network driving preterm birth

Key Points

Preterm birth rates decrease with KLF4 downregulation, highlighting its significance in inflammatory processes.
KLF4's regulatory influence on Ccl2+ fibroblasts suggests new therapeutic approaches to prevent preterm birth.
Analysis shows that infection-driven inflammation can lead to adverse pregnancy outcomes through KLF4 pathways.
Targeting KLF4 in treatment could significantly mitigate risks associated with preterm birth, emphasizing its potential.

Abstract

This study reveals that the fibroblast subpopulation Ccl2+fib contributes to preterm birth through a KLF4-dependent inflammatory regulatory network. KLF4 downregulation significantly reduces infection-induced preterm birth rates and adverse pregnancy outcomes, suggesting that KLF4 is a critical therapeutic target for preterm birth.

Bookmark

View Full Paper